Rhythm Biosciences Ltd has released a press release.
Genetype Commercial Integration Completion
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Quarterly Activities Report and Appendix 4C - Dec24
- About the Genetype Acquisition
- Completion of Genetype Risk Assessment Portfolio Acquisition
- RHY Acquires Genetype Genetic Risk Assessment Business
- Pause in Trading
Later from Rhythm Biosciences
- RHY Investor Webinar
- RHY Genetype Commercial Sales
- EGM - Investor Presentation
- Quarterly Activities Report and Appendix 4C 31 March 2025
- Breast Cancer Risk Study University of Melbourne
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences